Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Waste Management Stock: Navigating the Path to Recovery

Robert Sasse by Robert Sasse
November 14, 2025
in Analysis, Industrial, Turnaround
0
Waste Management Stock
0
SHARES
122
VIEWS
Share on FacebookShare on Twitter

The waste disposal sector is undergoing a digital transformation, but will this be sufficient to propel Waste Management’s share price upward? The environmental services provider finds itself at a crossroads, grappling with conflicting signals as rising revenue forecasts clash with compressed profitability margins and volatile commodity prices. Investors are watching closely to see if the company can reverse its current downward trajectory.

Leadership Transition and Strategic Initiatives

A significant leadership change is scheduled for November 2025, as Chief Financial Officer Devina Rankin retires after a 23-year tenure. Her successor, David Reed, brings extensive financial and operational expertise to the role, positioning him to tackle the company’s immediate challenges. This transition coincides with a strategic push focused on targeted acquisitions to densify its service network and expand internal processing capabilities.

Concurrently, Waste Management is intensifying its pricing strategies and leveraging technology to drive down operational expenses. However, this very digitalization presents a near-term hurdle, requiring substantial capital investments that are currently weighing on profit margins.

Cautious Analyst Sentiment Amidst Mixed Forecasts

Market experts maintain a guardedly optimistic stance. Sixteen analysts continue to endorse a “Moderate Buy” rating for the stock. While the average price target of $248.79 suggests a potential upside exceeding 21 percent, this is contingent on the company’s successful execution of its strategic plans.

Should investors sell immediately? Or is it worth buying Waste Management?

Analysts have made a minor adjustment to their price objective, lowering it from $246.64 to $246.09. This revision reflects concerns over profitability, as the net profit margin forecast was trimmed from 13.60 percent to 13.50 percent. On a more positive note, the revenue growth projection was upgraded, climbing from 5.89 percent to 6.06 percent, indicating underlying operational strength in a difficult market.

Headwinds in the Recycling Segment

The company’s 2025 outlook clearly reveals its vulnerabilities. With a revenue forecast of $25.275 billion, the company is positioned at the lower end of its previous guidance. The recycling business, once a core profit driver, has become a significant burden. This deterioration is primarily attributed to falling prices for recycled commodities and diminished returns from the health services segment.

A Glimmer of Hope in Market Sentiment

One encouraging data point emerges from short-selling activity. The short interest in Waste Management shares declined by 8.86 percent, signaling a reduction in outright pessimism among certain investors. Despite this shift, the stock’s recent performance remains weak, having lost more than 3.5 percent over the past month and continuing to trade below its key moving averages.

The central question for investors remains whether Waste Management can successfully balance its growth ambitions with the imperative of restoring profitability. The strategic direction has been set; the market now awaits tangible results from its implementation.

Ad

Waste Management Stock: Buy or Sell?! New Waste Management Analysis from February 8 delivers the answer:

The latest Waste Management figures speak for themselves: Urgent action needed for Waste Management investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Waste Management: Buy or sell? Read more here...

Tags: Waste Management
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Quanterix Stock
Analysis

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Next Post
BigBear.ai Stock

BigBear.ai Shares Experience Volatile Trading Week

BioXcel Stock

BioXcel Therapeutics: A Race Against Time

Redwood Stock

Bondholders Face Dividend-Related Setback with Redwood Trust Notes

Recommended

Biotechnology Stock Exchange

Analysts Bullish on Dynatrace with Price Targets on the Rise

2 years ago
The Trade Desk Stock

The Trade Desk Faces Mounting Pressure as Amazon Strikes Netflix Deal

5 months ago

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Trending

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

by Jackson Burston
February 8, 2026
0

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its...

Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com